top of page
Stack of Magazines

Liste des publications

2023

Guidi R., Wedeles C., Xu D., Kolmus K., Headland S.E., Teng G., Guillory J., Zeng Y.J., Cheung T.K., Chaudhuri S., Modrusan Z., Liang Y., Horswell S., Haley B., Rutz S., Rose C., Franke Y., Kirkpatrick D.S., Hackney J.A., Wilson M.S. (2023) Argonaute3-SF3B3 complex controls pre-mRNA splicing to restrain type 2 immunity. Cell Reports 42(12):113515. doi.org/10.1016/j.celrep.2023.113515 

Tong A-J., Leylek R., Herzner A-M., Rigas D., Wichner S., Blanchette C., Tahtinen S., Kemball C.C., Mellman I., Haley B., Freund E.C., Delamarre L. (2023) Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage. Journal of Experimental Medicine 221(2): e20230341. doi.org/10.1084/jem.20230341

Gurung H., Heidersbach A., Darwish M., Chan P., Li J., Beresini M., Zill O., Wallace A., Tong A-J., Hascall D., Torres E., Chang A., Lou K., Abdolazimi Y., Moore A., Uche U., Laur M., Notturno R., Ebert P.J.R., Blanchette C., Haley B., Rose C.M. (2023) Discovery of prevalent, clinically actionable tumor neoepitopes via integrated biochemical and cell-based platforms. Nature Biotechnology. Epub ahead of print. doi.org/10.1101/2022.10.27.513529

Ortiz-Muñoz G., Brown M., Carbone C.B., Pechuan-Jorge X., Rouilly V., Lindberg H., Ritter A.T., Raghupathi G., Sun Q., Nicotra T., Mantri S.R., Yang A., Doerr J., Nagarkar D., Darmanis S., Haley B., Mariathasan S., Wang Y., Gomez-Roca C., de Andrea C.E., Spigel D., Wu T., Delamarre L., Schöneberg J., Modrusan Z., Price R., Turley S.J., Mellman I., Moussion C. (2023) In situ tumour arrays reveal early environmental control of cancer immunity. Nature 618:827-833. doi.org/10.1038/s41586-023-06132-2

Heidersbach A.J., Dorighi K.M., Gomez J.A., Jacobi A.M., Haley B(2023) A versatile, high-efficiency platform for CRISPR-based gene activation.Nature Communications

14(1):902.doi:https://doi.org/10.1038/s41467-023-36452-w 

Freund E.C., Haag S.M., Haley B., Murthy A. Optimized Nonviral Gene Disruption in Primary Murine and Human Myeloid Cells. (2023) Methods in Molecular Biology 2618:201-217. doi: 10.1007/978-1-0716-2938-3_15

Calses P.C., Pham V.C., Guarnaccia A.D., Choi M., Verschueren E., Bakker S.T., Pham T.H., Hinkle T., Liu C., Chang M.T., Kljavin N., Bakalarski C., Haley B., Zou J., Yan C., Song X., Lin X., Rowntree R., Ashworth A., Dey A., Lill J.R. (2023) TEAD proteins associate with DNA repair proteins to facilitate cellular recovery from DNA damage. Molecular & Cellular Proteomics 22(2):100496. doi.org/10.1016/j.mcpro.2023.100496

2022

Chen H., Durinck S., Patel H., Foreman O., Mesh K., Eastham J., Caothien R., Newman R.J., Roose-Girma M., Darmanis S., Warming S., Lattanzi A., Liang Y., Haley B. (2022) Population-wide gene disruption in the murine lung epithelium via AAV-mediated delivery of CRISPR-Cas9 components. Molecular Therapy - Methods & Clinical Development. 27:431-449. doi.org/10.1016/j.omtm.2022.10.016

Pribluda A., Daemen A., Lima A.N., Wang X., Hafner M., Poon C., Modrusan Z., Katakam A.K., Foreman O., Eastham J., Hung J., Haley B., Garcia J.T., Jackson E.L., Junttila M.R. (2022) EHMT2 methyltransferase governs cell identity in the lung and is required for KRASG12D tumor development and propagation. Elife (11):e57648. doi.org/10.7554/eLife.57648

Deng Y., Diepstraten S.T., Potts M.A., Giner G., Trezise S., Ng A.P., Healey G., Kane S.R., Cooray A., Behrens K., Heidersbach A., Kueh A.J., Pal M., Wilcox S., Tai L., Alexander W.S., Visvader J.E., Nutt S.L., Strasser A., Haley B., Zhao Q., Kelly G.L., Herold M.J. (2022) Generation of a CRISPR activation mouse that enables modeling of aggressive lymphoma and interrogation of venetoclax resistance. Nature Communications 13(1):4739. doi.org/10.1038/s41467-022-32485-9

Oh S.A., Senger K., Madireddi S., Shaw D., Akhmetzyanova I., Ishizuka  I.E., Tarighat S., Lo J.H., Shaw D., Haley B., Rutz S. (2022) High efficiency, multiplexed non-viral engineering of human T cells using plasmid donor DNA.  Journal of Experimental Medicine. 219(5):e20211530. 

doi.org/10.1084%2Fjem.20211530

Zimmerman-Savill K.M., Lee B.B., Oeh J., Lin J., Lin E., Chung W-J., Young A., Chen W., Mis M., Mesh K., Eastham J., Gnad F., Jiang Z., Stawiski E.W., Haley B., Daemen A., Want X., Koeppen H., Modrusan Z., Martin S.E., Sampath D., Lin K. (2022) Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors. Nature Communications 13(1):2057. doi.org/10.1038/s41467-022-29655-0

Tahtinen S., Tong A-J., Himmels P., Oh J., Paler-Martinez A., Kim L., Wichner S., Oei Y., McCarron M.J., Freund E.C., Amir Z.A., de la Cruz C.C., Haley B., Blanchette C., Schartner J.M., Ye W., Yadav M., Sahin U., Delamarre L., Mellman I. (2022) IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nature Immunology 23:532–542. doi.org/10.1038/s41590-022-01160-y

 

Venkatanarayan A., Liang J., Yen I., Shanahan F., Haley B., Phu L., Verschueren E., Hinkle T.B., Kan D., Segal E., Long J.E., Lima T., Liau N.P.D., Sudhamsu J., Li J., Klijn C., Piskol R., Junttila M.R., Shaw A.S., Merchant M., Chang M.T., Kirkpatrick D.S., Malek S. (2022) CRAF dimerization with ARAF regulates KRAS-driven tumor growth. Cell Reports 38(6):110351. doi.org/10.1016/j.celrep.2022.110351

 

Carver J., Kern M., Ko P., Greenwood-Goodwin M., Yu X.C., Duan D., Tang D., Misaghi S., Auslaender S., Haley B., Yuk I.H., Shen A. (2022) A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering. Biotechnology Progress 38(1):e3212. doi.org/10.1002/btpr.3212

 

Chang M.T., Shanahan F., Nguyen T.T.T., Staben S.T., Gazzard L., Yamazoe S., Wertz I.E., Piskol R., Yang Y.A., Modrusan Z., Haley B., Evangelista M., Malek S., Foster S.A., Ye X. (2022) Identifying transcriptional programs underlying cancer drug response with TraCe-seq. Nature Biotechnology 40(1):86-93. doi.org/10.1038/s41587-021-01005-3

 

Senger, K., Akhmetzyanova I., Haley B., Rutz, S., Oh, S. (2022) Plasmid-based donor templates for non-viral CRISPR/Cas9-mediated gene knock-in in human T cells. Current Protocols 2022 2(9):e538.  doi.org/10.1002/cpz1.538


Senger K. and Haley B. (2022) Non-viral alternatives to delivery of CRISPR-Cas gene editing components.CRISPR-Cas9 Based Genome Editing for Treating Genetic Disorders and Diseases. CRC Press.183-223. eBook:9781003088516

Département d'ophtalmologie, Université de Montréal Centre de recherche de l'Hôpital Maisonneuve-Rosemont
Pavillon Claudine D'Amours
5415 Boul. de l'Assomption
Montréal, QC, Canada H1T 2M4

UdeM logo v2_edited.png
bottom of page